Scarica l'app Stockscreener
0.00
2.94%
-0.102
Precedente Chiudi:
$0.102
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
$-20.62M
Rapporto P/E:
0.00
EPS:
-18.54
Flusso di cassa netto:
$-17.61M
1 W Prestazione:
-2.94%
1M Prestazione:
-22.22%
6M Prestazione:
-74.07%
1 anno Prestazione:
+623.57%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$0.00
Neximmune Inc Stock (NEXI) Company Profile
Confronta NEXI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NEXI
Neximmune Inc
|
0.00 | 0 | 0 | -20.62M | -17.61M | -18.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.79 | 115.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.13 | 81.34B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.75 | 52.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.70 | 51.59B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.47 | 37.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neximmune Inc Stock (NEXI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-04-01 | Iniziato | Raymond James | Outperform |
| 2021-03-09 | Iniziato | Barclays | Overweight |
| 2021-03-09 | Iniziato | Cantor Fitzgerald | Overweight |
Neximmune Inc Borsa (NEXI) Ultime notizie
NexImmune (NASDAQ:NEXI) Stock Price Up 2,169,900% – Here’s Why - Defense World
NexImmune (NASDAQ:NEXI) versus Avenue Therapeutics (NASDAQ:ATXI) Head-To-Head Comparison - Defense World
Aktis Oncology files for US IPO as biotech listings rebound - marketscreener.com
Nasdaq Inc will be open as scheduled on Wednesday, December 24, 2025, and Friday, December 26, 2025 - marketscreener.com
Intellego board has asked Nasdaq to keep trading halted - marketscreener.com
Tradeweb CEO says round-the-clock trading to become mainstream - marketscreener.com
Alerts, brief on Cybin transferring US listing to Nasdaq withdrawn - marketscreener.com
Nasdaq sees bigger year ahead for listings on billion-dollar-plus IPOs - marketscreener.com
Ben strengthens balance sheet with over $1.24 million in liability reductions - marketscreener.com
Blank Check Co, Proem Acquisition Corp I files for IPO of up to $130 million - marketscreener.com
RTW Biotech invests USD5.9 million in Yarrow Bioscience funding round - marketscreener.com
Launchpad Cadenza Acquisition Corp I Prices IPO - marketscreener.com
SS Lazio, a global brand between the stock market and US ambitions - marketscreener.com
Nasdaq seeks to extend trading hours to nearly round-the-clock - marketscreener.com
Bitcoin hoarding company Strategy remains in Nasdaq 100 - marketscreener.com
Nasdaq submits new plan with more power to block IPOs vulnerable to manipulation - marketscreener.com
Nasdaq seeks more power to block IPOs vulnerable to manipulation - marketscreener.com
Critical Survey: NexImmune (NASDAQ:NEXI) and Palatin Technologies (PINK:PTNT) - Defense World
Critical Review: NexImmune (NASDAQ:NEXI) and Eagle Pharmaceuticals (NASDAQ:EGRX) - Defense World
NexImmune (NASDAQ:NEXI) versus iBio (NYSE:IBIO) Financial Survey - Defense World
Head-To-Head Survey: NexImmune (NASDAQ:NEXI) versus Evotec (OTCMKTS:EVTCY) - Defense World
Central Bancompany valued at $5.26 billion in Nasdaq debut - marketscreener.com
Wall Street opens higher as Nvidia test looms - marketscreener.com
Sampo Gets Berenberg’s Vote As Nordic Insurance Leader - Finimize
Total debt per share of NexImmune, Inc. – LS:A3EUTV - TradingView
Evolution Global Acquisition Shares Rise in Nasdaq Debut - marketscreener.com
Nasdaq Scores Best Day Since May on Optimism Over Shutdown Resolution - marketscreener.com
EU Antitrust Watchdog Probes Deutsche Boerse, Nasdaq Over Financial Derivatives -- Update - marketscreener.com
BlackRock-backed TXSE Group adds US banking giant J.P. Morgan as investor - marketscreener.com
Gloo, with former Intel CEO Gelsinger as tech head, seeks nearly $900 million valuation in IPO - marketscreener.com
Clean Energy Technologies, Inc. regains compliance with Nasdaq listing requirements - marketscreener.com
Qt Imaging Holdings IncSubmits application to relist on Nasdaq - marketscreener.com
NexImmune, Inc. (NEXI) stock price, news, quote and history - Yahoo
Functional Brands expects common stock to begin trading on Nasdaq on or about November 4 - marketscreener.com
Book value per share of NexImmune, Inc. – LS:A3EUTV - TradingView
Light & Wonder announces update on Nasdaq delisting timetable - marketscreener.com
Datavault AI Regains Compliance With Nasdaq Listing Rule - marketscreener.com
Wall Street indexes fall as data raises uncertainty for rate-cut outlook - MarketScreener
Nasdaq & AWS to advance capital markets and banking infrastructure across the financial system - MarketScreener
Tech Values, Fed Outlook Cramp Wall Street Pre-Bell; Asia Mixed, Europe Off - MarketScreener
Rick Perry's data center REIT Fermi targets $13 billion valuation in US IPO - MarketScreener
Wall Street indexes end lower as investors digest Powell comments - MarketScreener
Blank check company, Lafayette Digital Acquisition Corp Ifiles for IPO of up to $250 millionSEC filing - MarketScreener
Thunderstone Acquisition Corp intend to apply units on Nasdaq - MarketScreener
Galata Acquisition Corp. II Closes $172.5 Million IPO - MarketScreener
Voltage X intends to list shares on Nasdaq as 'VXAI' - MarketScreener
Creative Future Acquisition Corp files for IPO of up to $60 mln - MarketScreener
Wall St closes higher with indexes notching weekly gains - MarketScreener
Blank check company Spacsphere Acquisition Corp files for IPOSEC filing - MarketScreener
Ultragenyx reports inducement grant under Nasdaq - MarketScreener
Su group receives notice of delisting from Nasdaq - MarketScreener
Neximmune Inc Azioni (NEXI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.28%
0.07%
Capitalizzazione:
|
Volume (24 ore):